Related Experiment Video
Updated: Aug 9, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not
Mihai Merzianu1, Liuyan Jiang, Pei Lin
1Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Insights
Nuclear B-cell lymphoma 10 (BCL-10) expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM), occurring in 55% of cases. This finding is independent of MALT lymphoma-associated translocations and NF-kappaB activation.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- B-cell lymphoma 10 (BCL-10) is crucial for lymphocyte development and activation, with aberrant nuclear expression linked to certain lymphomas.
- Its role in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) remains largely uncharacterized.
Purpose of the Study:
- To investigate the expression patterns of BCL-10 in bone marrow specimens of patients with LPL/WM.
- To assess the correlation of BCL-10 expression with disease extent and nuclear factor-kappa B (NF-kappaB) activation.
Main Methods:
- Immunohistochemical analysis of BCL-10 and p65 NF-kappaB subunit in 51 LPL/WM bone marrow specimens.
- Assessment of BCL-10 expression extent and pattern within neoplastic B-cells.
- Cytogenetic analysis for specific translocations (t(1;14) and t(11;18)) in a subset of cases.
Main Results:
- Nuclear BCL-10 staining was observed in 55% (28/51) of LPL/WM specimens.
- BCL-10 expression significantly correlated with a greater extent of bone marrow involvement (P=0.001).
- Nuclear p65 NF-kappaB was detected in 34% (17/50) of cases, but did not correlate with BCL-10 expression or MALT lymphoma-associated translocations.
Conclusions:
- Nuclear BCL-10 expression is a frequent finding in LPL/WM.
- The presence of nuclear BCL-10 in LPL/WM is not associated with the translocations typically seen in MALT lymphomas.
- NF-kappaB pathway activation occurs in a subset of LPL/WM but is not directly linked to nuclear BCL-10 staining in this cohort.
Abstract:
B-cell lymphoma 10 (BCL-10) is expressed in the cytoplasm of normal germinal center and marginal zone B-cells and is involved in lymphocyte development and activation. Aberrant nuclear expression of BCL-10 occurs in a subset of extranodal marginal zone B-cell lymphomas (MALT lymphomas), primarily those with the t(1;14)(p22;q32) or t(11;18)(q21;q21). Little is known about BCL-10 expression in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM). We assessed for BCL-10 in 51 bone marrow (BM) specimens involved by LPL/WM using immunohistochemical methods. All patients had monoclonal IgM in serum. Extent of BM involvement was assessed using PAX-5/BSAP and CD20 immunostains and the pattern and percentage of B-cells positive for BCL-10 was determined. The p65 subunit of nuclear factor-kappa B (NF-kappaB), a molecule downstream of BCL-10, was also assessed immunohistochemically. Nuclear BCL-10 staining was present in 28/51 (55%) specimens. BCL-10 expression correlated with greater extent of BM involvement (P=0.001), but did not correlate with serum IgM paraprotein levels, type of immunoglobulin light chain, or clinical variables. Nuclear expression of the p65 subunit of NF-kappaB was detected in 17/50 (34%) specimens, suggesting that NF-kappaB is active in a subset of LPL/WM. p65 NF-kappaB activation did not correlate with nuclear BCL-10 immunostaining. Cytogenetic analysis in 29 cases showed no evidence of the t(1;14) or t(11;18). These results indicate that nuclear BCL-10 expression is common in LPL/WM and does not correlate with MALT lymphoma-associated translocations or p65 NF-kappaB nuclear staining.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Co-activators and Co-repressors
Nuclear Localization Signals and Import
